Objective: To describe fetal macrocrania including prenatal diagnosis, delivery considerations and clinical outcomes. Result: Twenty-three fetuses were diagnosed with macrocrania. Median gestational age at diagnosis was 31.1 weeks (range 18.3-38.1) and at delivery was 36.9 weeks (range 30.7-39.9). Fifteen patients (65%) underwent amniocentesis for karyotype; none were aneuploid but one had a duplication on chromosome 7. All the 23 infants were liveborn. Twentyone deliveries were by Cesarean (91%), with thirteen of these by classical incision (62%). Of the infants, 5 (22%) died shortly after birth, 16 (70%) were stabilized in the neonatal intensive care unit and were discharged alive and 2 (8%) were transferred to another center and subsequently died. Eighteen babies required ventriculoperitoneal shunting (78%).
Introduction
Terms used to describe a large head are often used interchangeably. However, this is incorrect because the different terms represent different entities. Making the distinction is important because use of the correct term may yield information about the underlying process causing the clinical finding, and may confer information about prognosis and/or management. Macrocrania is defined as an abnormal increase in the size of the skull, with the facial area being disproportionately small in comparison. In contrast, macrocephaly is excessive size of the whole head, whereas megalencephaly represents overgrowth of the brain. 1 Macrocrania is a term rarely encountered in obstetrics or prenatal diagnosis but is a very common diagnosis in pediatrics and in radiology, affecting up to 5% of pediatric patients. 2 Unfortunately, diagnostic criteria are inconsistent. A review of the literature on the topic shows criteria that are both objective and subjective. Objective measures are inconsistent from study to study and include children with a head circumference >95th-98th percentile for age, disproportionate head size compared with body length and weight, and rapidly enlarging head circumference on serial measurements. 3, 4 The descriptors 'disproportionate' and 'rapidly enlarging' are not well defined. A large-appearing head by observation is an example of a subjective measure. 4 In the pediatric population, macrocrania is most commonly due to abnormal fluid collections in the head. 3 These most commonly include abnormalities in the ventricular system of the central nervous system (ventriculomegaly) or external hydrocephalus (abnormal fluid collection in the subarachnoid space with normal cerebral ventricles). 2 When ventriculomegaly is noted, this is most often due to obstruction in the flow of cerebrospinal fluid, such as is seen with stenosis or atresia of the aqueduct of Sylvius. 4 Other differential diagnostic considerations when macrocrania is encountered include space occupying lesions such as tumors, hemorrhages, large arachnoid cysts and myelomeningoceles. 2, 5 It has long been advocated that children considered to have macrocrania be evaluated with imaging studies to determine the need for surgical versus nonsurgical management. 2, 6 Which modality to use is the subject of some debate. The classic way to evaluate children with macrocrania was to use ventriculography and cerebral angiography. Due to the desire to avoid these invasive tests in children, these were limited to only the most severe cases.
The introduction of computed tomography (CT) permitted noninvasive evaluation of these cases, allowing those with lesser degrees of head enlargement to be included. 3 Cranial ultrasound has since been shown to correlate well with CT, with no significant abnormality missed using this modality. This, coupled with the desire to avoid ionizing radiation in children, led to cranial ultrasonography being advocated as a first line method of imaging the head in pediatrics. 4 CT or magnetic resonance imaging is now used in cases that are unclear, finer discrimination is needed, or for imaging the external subarachnoid spaces. 6 Given the frequency of ultrasonography during pregnancy and that evaluation of the head and intracranial contents is a part of each targeted sonogram, many of the same diagnoses made in children with macrocrania should be made in the fetus. The paucity of information in the obstetric literature regarding the prenatal diagnosis of macrocrania, the associated obstetric management and outcomes is striking. Accordingly, we created this retrospective case series at our tertiary referral center so that we could better counsel patients and referring physicians when a fetus with an abnormally large head is encountered on ultrasound. Our main interests included demographics of patients whose fetuses were diagnosed with macrocrania, obstetric management and delivery considerations in these pregnancies and outcomes including duration of stay in the neonatal intensive care unit (NICU), need for surgery shortly after delivery and ultimate survival.
Methods
The Institutional Review Board of the University of Mississippi Medical Center (UMC), the primary perinatal referral center for the state of Mississippi, approved this retrospective review of deidentified data (IRB File no. 2007-0016). Sonographers, maternal-fetal medicine fellows and attending physicians performed all ultrasounds in the Antenatal Diagnostic Unit at UMC. Ultrasound studies performed during a 52-month period from March 2003 to June 2007 were reviewed and those cases in which the prenatal diagnosis of macrocrania was suspected were identified. This was followed by a review of both maternal and neonatal medical records. Demographic variables, fetal information including diagnoses, obstetric management including amniocentesis and results, timing and mode of delivery and neonatal data including survival were recorded for each mother/infant pair.
Diagnostic criteria were based on those used for children after birth. However, choosing a particular percentile above which we could make the diagnosis would have been arbitrary given the discrepancies by different authors in the pediatric literature as described above. Therefore, we considered a fetus to have macrocrania if either or both of the following were met:
(1) A rapidly enlarging head as evidenced by the head measurements (head circumference and biparietal diameter)
outpacing the other biometric parameters by greater than or equal to 4 weeks size. (2) Fetal head size greater than would likely be successfully delivered vaginally as evidenced by a biparietal diameter of greater than or equal to 11 cm (given that a completely dilated cervix is usually 10 cm).
Results
A total of 26 885 ultrasound studies were reviewed and 23 fetuses diagnosed with macrocrania were identified. None were lost to follow-up and all deliveries were at our institution. The demographics of this cohort are summarized in Table 1 . Fifteen patients (65%) underwent genetic amniocentesis; none were aneuploid but one had a duplication on chromosome 7. All the 23 fetuses were liveborn. Continuous variables regarding infant birth data are summarized in Table 2 . Fifteen infants (65%) were male. 1-20) . The underlying causes of the macrocrania encountered on prenatal sonography are listed in Table 3 . All diagnoses were confirmed after delivery by appropriate imaging, consultation and autopsy where appropriate. A patient-by-patient summary of ultrasound findings, diagnoses (before and after delivery), outcomes and length of NICU stay can be seen in Table 4 .
Discussion
This case series documents our experience with fetal macrocrania, and to our knowledge is the first to specifically describe the diagnosis prenatally. Therefore, our data may be Our median gestational age at diagnosis (31.1 weeks) is somewhat later than expected. However, in our study the most frequent cause of macrocrania was stenosis/atresia of the aqueduct of Sylvius. This leads to progressive ventriculomegaly and although the diagnosis of ventriculomegaly can be made earlier in gestation, the diagnosis of macrocrania is only possible after weeks or months when the ventriculomegaly has become severe enough to cause marked expansion of the fetal head.
The median gestational age at delivery (36.9 weeks) is more a reflection of the management of these patients than the natural history of infants with macrocrania. Management of prenatal patients with suspected fetal macrocrania at the University of Mississippi includes observation with monthly scans to follow the size of the head and amniocentesis at 37 weeks followed by delivery if lung maturity is documented. This strategy allows for patients from our fairly rural state to deliver at a tertiary institution. Indeed, 70% of infants (16/23) in this series underwent amniocentesis for fetal lung maturity, whereas the other 30% had preterm labor or an indicated preterm delivery before undergoing the amniocentesis as planned.
The underlying diagnoses leading to fetal macrocrania in this series were similar to that recorded in pediatric populations. Donat reported in 1981 that hydrocephalus from ventriculomegaly is the leading cause of macrocrania in children, 3 and the current case series echoes this finding. Babcock et al. reported in 1988 that in infants with macrocrania, 5 of 11 (45.5%) infants with significantly abnormal findings on cranial sonography had aqueductal stenosis. 4 This is very similar to the 43.5% incidence of aqueductal stenosis reported in this series.
We noted a majority of male fetuses diagnosed with macrocrania. Our 65% male predominance is very close that previously reported in children. Medina reported 59 of 88 (67%) children diagnosed with macrocrania were male, 2 whereas Donat reported 53 of 72 (73.6%) children were male. 3 This might be explained by the high number of diagnoses of aqueductal stenosis, which is known to have an X-linked form.
Ventriculoperitoneal shunting was required in this series in 78% of infants. However, this is much higher than expected, based on pediatric literature. Medina et al. reported in 2001 that only 18% of children with macrocrania required surgical treatment. 2 This marked difference is likely due to worse ventriculomegaly in those infants diagnosed prenatally. Further, some of the infants shunted in this series did not survive and therefore may not have been included in pediatric investigations.
There were no intrauterine fetal demises. However, our overall survival rate with prenatally diagnosed macrocrania was only 70%. This reflects the diagnoses made underlying the macrocrania and will vary from case to case. For example, all three of the infants with the VATER anomalad and the infant with hydranencephaly died shortly after birth but all cases with isolated aqueductal stenosis survived. Long-term outcomes for survivors will also vary based upon the underlying diagnoses and are a potential further course of investigation. The pediatric literature reflects that infants do well if the macrocrania is due to external hydrocephalus or mild ventriculomegaly. 2, 4, 6, 7 However, when moderate to severe ventriculomegaly is noted, especially when associated with cerebral atrophy, outcomes are poor. Bosnjak et al. reported only 2 of 20 patients with cerebral atrophy were neurologically normal at presentation and in most cases the initial abnormal finding persisted at follow-up. 6 Babcock et al. reported that 19% of term infants and 25% of preterm infants with macrocrania were neurologically or developmentally abnormal on follow-up that ranged from 1 month to 5 years. 4 The diagnosis of macrocrania has also been linked to epilepsy and autistic disorders. 8 In summary, the diagnosis of macrocrania is possible prenatally. Fetal macrocrania is usually a result of ventriculomegaly due to an obstructive process to cerebrospinal fluid flow. Suspicion for macrocrania necessitates a targeted sonographic evaluation by personnel experienced in prenatal diagnosis to evaluate for the underlying pathology leading to the macrocrania. This allows extensive counseling of parents, arrangements for delivery at a tertiary care center with availability of neurosurgery, and evaluation for mode of delivery. Abdominal delivery is usually required, often necessitating a classical uterine incision.
